CH5138303
CAS No. 959763-06-5
CH5138303( CH5138303 | CH-5138303 | CH 5138303 )
Catalog No. M19285 CAS No. 959763-06-5
CH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 203 | In Stock |
|
| 10MG | 324 | In Stock |
|
| 25MG | 584 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCH5138303
-
NoteResearch use only, not for human use.
-
Brief DescriptionCH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM.
-
DescriptionCH5138303 is a novel and potent HSP90 inhibitor. CH5138303 showed high binding affinity for N-terminal Hsp90α (Kd=0.52nM) and strong in vitro cell growth inhibition against human cancer cell lines (HCT116 IC50=0.098μM, NCI-N87 IC50=0.066μM) and also displayed high oral bioavailability in mice (F=44.0%) and potent antitumor efficacy in a human NCI-N87 gastric cancer xenograft model (tumor growth inhibition=136%).
-
In VitroWhen used in combination with FLC, CH5138303 shows antifungal activitiy against azole-resistant C. albicans, with a FICI (fractional inhibitory concentration index) of 0.500.
-
In VivoCH5138303 (SCID mice bearing NCI-N87 cells, 0-50 mg/kg, Orally, once daily for 11 days) shows potent antitumor efficacy with TGI (tumor growth inhibition) of 136% and a median effective dose (ED50) of 3.9 mg/kg without significant loss of body weight.
-
SynonymsCH5138303 | CH-5138303 | CH 5138303
-
PathwayEndocrinology/Hormones
-
TargetReductase
-
RecptorHSP90α
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number959763-06-5
-
Formula Weight415.9
-
Molecular FormulaC19H18ClN5O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNC(=O)CCCSC1=NC(N)=NC(=N1)C1=C(Cl)C=C2COCC3=CC=CC1=C23
-
Chemical Name4-((4-amino-6-(5-chloro-1,3-dihydrobenzo[de]isochromen-6-yl)-1,3,5-triazin-2-yl)thio)butanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Suda A, et al. Bioorg Med Chem. 2014, 22(2), 892-905.
molnova catalog
related products
-
beta-Glucogallin
beta-Glucogallin (beta-Glucogallin) is a selective aldose reductase (AKR1B1) inhibitor with antioxidant, anti-glycation, and anti-inflammatory properties.
-
Saikosaponin B2
Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells.
-
Ponalrestat
ponalrestat, an aldose reductase inhibitor, activates lipoprotein lipase (LPL) activity in the adipose tissue and alleviates the cachectic symptoms induced by B16 melanoma in mice
Cart
sales@molnova.com